Histocompatibility Testing 1984 1984
DOI: 10.1007/978-3-642-69770-8_118
|View full text |Cite
|
Sign up to set email alerts
|

Insulin-Dependent Diabetes Mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

7
30
0
3

Year Published

1987
1987
2007
2007

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 93 publications
(40 citation statements)
references
References 7 publications
7
30
0
3
Order By: Relevance
“…The number of autoantibodies positive patients is far less than that of autoanfibodies negative patients among Japanese [21], and therefore, an increase in HLA-DRw9 found in autoantibodies positive patients might not be obvious if HLA-DR association is a Auto Ab=autoantibodies other than ICA; ATGA=antithyro-globulin antibody, ATMA=antithyromicrosome antibody, AGA= antigastric antibody, AAA = antiadrenal antibody; DR4/X = positive for HLA-DR4 but negative for HLA-DRw9, DRw9/X=positive for HLA-DRw9 but negative for HLA-DR4, DR4/9=posifive for both HLA-DR4 and DRw9; n =number of patients studied b p < 0.02 (male vs female) DR4/X~positive for HLA-DR4 but negative for HLA-DRw9, DRw9/X=positive for HLA-DRw9 but negative for HLA-DR4, DR4/9 = positive for both HLA-DR4 and DRw9 analysed in Type 1 diabetic patients in general. Recently, HLA-DR4 and DRw9 have been reported to be associated with Type I diabetes among Orientals including Japanese [22], which is in accord with the present study. The difference in HLA-DR phenotypes between Japanese and Caucasian Type 1 diabetic patients -HLA-DRw9 among Japanese and HLA-DR3 among Caucasians -is not likely to result from the difference in the nature of Type 1 diabetes between these two races, since there are no clinical differences in Type 1 diabetes between the two races, although the prevalence of a Auto Ab=organ-specific autoantibodies other than ICA; b cited from the data of the 8th Japan HLA Workshop [16]; RR=relative risk; NS = not significant; X = neither DRw9 nor DR4; n = number of patients studied; All comparisons were made against control subjects Type 1 diabetes is lower by 10-to 30-fold in Japanese than in Caucasians [9].…”
Section: Discussionsupporting
confidence: 92%
“…The number of autoantibodies positive patients is far less than that of autoanfibodies negative patients among Japanese [21], and therefore, an increase in HLA-DRw9 found in autoantibodies positive patients might not be obvious if HLA-DR association is a Auto Ab=autoantibodies other than ICA; ATGA=antithyro-globulin antibody, ATMA=antithyromicrosome antibody, AGA= antigastric antibody, AAA = antiadrenal antibody; DR4/X = positive for HLA-DR4 but negative for HLA-DRw9, DRw9/X=positive for HLA-DRw9 but negative for HLA-DR4, DR4/9=posifive for both HLA-DR4 and DRw9; n =number of patients studied b p < 0.02 (male vs female) DR4/X~positive for HLA-DR4 but negative for HLA-DRw9, DRw9/X=positive for HLA-DRw9 but negative for HLA-DR4, DR4/9 = positive for both HLA-DR4 and DRw9 analysed in Type 1 diabetic patients in general. Recently, HLA-DR4 and DRw9 have been reported to be associated with Type I diabetes among Orientals including Japanese [22], which is in accord with the present study. The difference in HLA-DR phenotypes between Japanese and Caucasian Type 1 diabetic patients -HLA-DRw9 among Japanese and HLA-DR3 among Caucasians -is not likely to result from the difference in the nature of Type 1 diabetes between these two races, since there are no clinical differences in Type 1 diabetes between the two races, although the prevalence of a Auto Ab=organ-specific autoantibodies other than ICA; b cited from the data of the 8th Japan HLA Workshop [16]; RR=relative risk; NS = not significant; X = neither DRw9 nor DR4; n = number of patients studied; All comparisons were made against control subjects Type 1 diabetes is lower by 10-to 30-fold in Japanese than in Caucasians [9].…”
Section: Discussionsupporting
confidence: 92%
“…The high level of DQw3 expression achieved in all cases indicates that an endogenous class II a chain was efficiently recruited for dimer formation and that the substitutions of variable residues at codons 13, 26, 45, and 57 did not interfere with this heterodimer formation. This DQ2 cell expressing the transfected DQ3.2,3 gene also provides an interesting model for IDDM immunogenetics: DR3/DR4 (DQ2/DQ3) heterozygous individuals have the highest relative risk for IDDM (18), suggesting some synergy between the HLA genetic contributions of these two haplotypes. In the present study, expression of the transfected DQ3.2p gene implies heterodimer formation between the endogenous DQ2a chain and the inserted DQ3.2.3 chain.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the role of HLA genetics in the aetiology of IDDM being well known [3,4] the role of putative environmental factors is not yet understood [5][6][7]. Epidemiologically based standardized surveillance systems provide information on the pattern of IDDM incidence which make comparison of IDDM incidence between countries within close geographical areas possible, thus offering an "indirect" way to trace potential environmental factors in the aetiology of IDDM.…”
mentioning
confidence: 99%